79,981 results match your criteria Libman-Sacks Endocarditis


Clinical predictive model to estimate probability of remission in patients with lupus nephritis.

Int Immunopharmacol 2022 Jun 25;110:108966. Epub 2022 Jun 25.

Department of Nephrology, West China Hospital, Sichuan University, No. 37, Guoxue alley, Chengdu, Sichuan Zipcode:610000, China. Electronic address:

Background: Lupus nephritis (LN) is a major organ complication and cause of morbidity and mortality in patients with systemic lupus erythematosus. This study aims to provide the clinician with a quantitative tool for the prediction of the individual remission probability of LN and obtain new insights for improved clinical management in LN treatment.

Methods: A total of 301 patients with renal biopsy-proven LN were recruited and randomly divided into model construction and validation group. Read More

View Article and Full-Text PDF

Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran.

Asian Pac J Cancer Prev 2022 Jun 1;23(6):1921-1926. Epub 2022 Jun 1.

Clinical Research Development Unit, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Hepatitis B virus is the causative agent for chronic, acute, cirrhosis, and hepatocellular carcinoma.  SLE patients with chronic or occult hepatitis B infection undergoing immunosuppressive drugs may become reactive and develop fatal hepatitis. Read More

View Article and Full-Text PDF

Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.

Expert Rev Clin Pharmacol 2022 Jun 28. Epub 2022 Jun 28.

Aurinia Pharmaceuticals Inc., Victoria, Canada.

Introduction: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus. Standard-of-care immunosuppressive therapies achieve poor complete renal response (CRR) rates, with considerable toxicity. This article reviews voclosporin, a novel oral calcineurin inhibitor (CNI) approved for treatment of adults with active LN by the US Food and Drug Administration (the FDA) in January 2021. Read More

View Article and Full-Text PDF

An Unusual Presentation of Systemic Lupus Erythematosus.

Kans J Med 2022 20;15:218-219. Epub 2022 Jun 20.

Geisinger Wyoming Valley Hospital, Wilkes Barre, PA.

View Article and Full-Text PDF

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice.

J Vis Exp 2022 Jun 8(184). Epub 2022 Jun 8.

Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University;

Systemic lupus erythematosus (SLE) is an autoimmune disorder with no known cure and is characterized by persistent inflammation in many organs, including the kidneys. Under such circumstances, the kidney loses its ability to clean waste from the blood and regulate salt and fluid concentrations, eventually leading to renal failure. Women, particularly those of childbearing age, are diagnosed nine times more often than men. Read More

View Article and Full-Text PDF

Associations of a family history of lupus with the risks of lupus and major psychiatric disorders in first-degree relatives.

QJM 2022 Jun 27. Epub 2022 Jun 27.

Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.

Background: Genetic factors link psychiatric disorders, particularly major depressive disorder (MDD), bipolar disorder, and obsessive-compulsive disorder (OCD), with systemic lupus erythematosus (SLE). Additionally, maternal SLE is a risk factor for long-term developmental problems, particularly learning disabilities, attention disorders, autism spectrum disorder (ASD), and speech disorders, in children.

Aim: We aimed to determine whether first-degree relatives (FDRs) of patients with SLE have increased risks of SLE and major psychiatric disorders. Read More

View Article and Full-Text PDF

Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.

Front Immunol 2022 10;13:861719. Epub 2022 Jun 10.

Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.

Background: Severe autoimmune haemolytic anaemia (AIHA) in systemic lupus erythematosus (SLE) patients could be life-threatening and formidable, especially in those nonresponsive to glucocorticoids (GCs) and immunosuppressants (ISAs). Whole-blood exchange transfusion (WBE), with plasma exchange and pathogenic cell removal as well as healthy red blood cell transfusion, could be beneficial. The objective of this study was to investigate the efficacy and safety of WBE in combination with GCs/ISAs. Read More

View Article and Full-Text PDF

Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells.

Front Immunol 2022 10;13:873787. Epub 2022 Jun 10.

Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.

Background: Systemic lupus erythematosus (SLE) is an autoimmune illness caused by a malfunctioning immunomodulatory system. China has the second highest prevalence of SLE in the world, from 0.03% to 0. Read More

View Article and Full-Text PDF

Low Serum Calcium Concentration in Patients With Systemic Lupus Erythematosus Accompanied by the Enhanced Peripheral Cellular Immunity.

Front Immunol 2022 10;13:901854. Epub 2022 Jun 10.

Institute of Pediatrics, The First Hospital of Jilin University, Jilin University, Changchun, China.

Objective: This study aims to explore the relationship between serum calcium concentration and peripheral lymphocyte status/Th1/Th2 cytokine levels in SLE patients, and the effect of glucocorticoids (GCs) on the calcium concentration and immune cell activation.

Methods: The peripheral blood TBNK lymphocyte subsets and Th1/Th2 cytokines in SLE patients with low or normal serum calcium concentration and healthy people were analyzed and compared retrospectively. Peripheral white blood cells (PWBCs) from SLE patients or healthy people were stimulated with PMA or GCs to test their extracellular calcium concentration and CD8 T cell activation. Read More

View Article and Full-Text PDF

Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus.

Front Immunol 2022 9;13:844025. Epub 2022 Jun 9.

Department of Rheumatology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, China.

Objective: This study was conducted to identify the biomarkers and mechanisms associated with systemic lupus erythematosus(SLE) at a transcriptome level.

Methods: Microarray datasets were downloaded, and differentially expressed genes (DEGs) were identified. Enrichment and protein-protein interaction networks were analyzed, and hub genes were discovered. Read More

View Article and Full-Text PDF

Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children.

Front Pediatr 2022 10;10:855445. Epub 2022 Jun 10.

Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Patients with inborn errors of immunity (IEI) are susceptible to developing a severe infection-related clinical phenotype, but the clinical consequences of immune dysregulation, expressed with autoimmunity, atopy, and lymphoproliferation could represent the first sign in a significant percentage of patients. Therefore, during the diagnostic work-up patients with IEI are frequently addressed to different specialists, including endocrinologists, rheumatologists, and allergologists, often resulting in a delayed diagnosis. In this paper, the most relevant non-infectious manifestations of IEI are discussed. Read More

View Article and Full-Text PDF

mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations.

Noncoding RNA Res 2022 Sep 26;7(3):142-149. Epub 2022 May 26.

Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), Sadat City University, Egypt.

This study aimed to investigate the genetic polymorphisms of miR-146a SNPs (rs2910164, rs57095329, and rs2431697) in systemic lupus erythematosus (SLE) patients and their association with clinical manifestations. The implication of SNPs on miR-146a expression level was also evaluated. SLE patients (113) and healthy controls (104) were registered in this study. Read More

View Article and Full-Text PDF
September 2022

Early-Age Manifestation of Singleton Merten Syndrome With Systemic Lupus Erythematosus Features: A Case Report.

Cureus 2022 May 23;14(5):e25244. Epub 2022 May 23.

Pediatrics, King Abdulaziz Medical City, Jeddah, SAU.

Singleton Merten syndrome (SMS) is one of the rarest multisystem genetic disorders that had been recognized in only a few cases. Patients who have this syndrome often present with calcification of the aorta and heart valves, dental dysplasia, joint calcification, distinct facial features, and growth and developmental delay. Other physical findings usually associated with SMS may include glaucoma, skeletal abnormalities including tendon rupture, muscle weakness, and arthropathy. Read More

View Article and Full-Text PDF

Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Front Med (Lausanne) 2022 9;9:875492. Epub 2022 Jun 9.

Department of Dermatology, University of Lübeck, Lübeck, Germany.

An estimated 20-25% of the population is affected by chronic, non-communicable inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most frequent chronic inflammatory skin diseases are atopic dermatitis, psoriasis, urticaria, lichen planus, and hidradenitis suppurativa, driven by a complex interplay of genetics and environmental factors. Read More

View Article and Full-Text PDF

Tph Cells Expanded in Primary Sjögren's Syndrome.

Front Med (Lausanne) 2022 9;9:900349. Epub 2022 Jun 9.

Division of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Objectives: PD-1CXCR5CD4T peripheral helper cells, named Tph cells, contribute to B-cell immune responses and the production of antibodies in systemic lupus erythematosus and rheumatoid arthritis. However, the role of Tph cells was unknown in the pathogenesis of primary Sjögren's syndrome (pSS). Here, we aim to explore the contribution of Tph cells in the development of pSS. Read More

View Article and Full-Text PDF

Follow-up of clinical activity and accumulated organic damage in a cohort of patients with systemic lupus erythematosus from the Yucatán Peninsula, Mexico (1995-2016).

Reumatol Clin (Engl Ed) 2022 Jun 23. Epub 2022 Jun 23.

Facultad de Medicina, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico.

Introduction: Systemic lupus erythematosus (SLE) is an autoimmune with variable severity, common in Hispanic and African-American individuals.

Objective: To know the clinical activity and the accumulated damage, as well as the prevalence and incidence, in a dynamic cohort of patients with SLE from the Yucatan Peninsula (1995-2016).

Patients And Methods: A cohort of 200 patients with SLE, medical service beneficiaries of the ISSSTE Regional Hospital of Mérida, Yucatán, was analysed for 22 years. Read More

View Article and Full-Text PDF

Disease spectrum of 9 310 cases of renal biopsy pathological diagnosis from a single center in China.

Zhong Nan Da Xue Xue Bao Yi Xue Ban 2022 May;47(5):546-554

Department of Nephrology, Second Xiangya Hospital, Central South University; Institute of Nephrology, Central South University, Changsha 410011, China.

Objectives: The pathological types of renal diseases have changed in the past decade, but it lacks large sample analysis in Hunan Province. This study aims to retrospectively analyze the composition characteristics of pathological spectrum of kidney disease in Hunan Province in recent 10 years, compare the changes of pathological types of kidney disease.

Methods: We collected a total of 9 310 kidney biopsy cases from 2011 to 2020 registered in the kidney biopsy system of the Nephrology Institute of the Second Xiangya Hospital of Central South University. Read More

View Article and Full-Text PDF

Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component.

Ann Rheum Dis 2022 Jun 26. Epub 2022 Jun 26.

Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan

Objectives: Autoimmune and allergic diseases are outcomes of the dysregulation of the immune system. Our study aimed to elucidate differences or shared components in genetic backgrounds between autoimmune and allergic diseases.

Methods: We estimated genetic correlation and performed multi-trait and cross-population genome-wide association study (GWAS) meta-analysis of six immune-related diseases: rheumatoid arthritis, Graves' disease, type 1 diabetes for autoimmune diseases and asthma, atopic dermatitis and pollinosis for allergic diseases. Read More

View Article and Full-Text PDF

Retinal vasculitis: A reliable marker of disease activity in childhood-onset systemic lupus erythematosus.

J Fr Ophtalmol 2022 Jun 22. Epub 2022 Jun 22.

Tecnologico de Monterrey, School of Medicine and Health Sciences, Institute of Ophthalmology and Visual Sciences, Monterrey, México, Hospital Zambrano Hellion Tec-Salud, Av. Batallon de San Patricio 112, Real San Agustín, 66278 San Pedro Garza García, N.L, Mexico.

View Article and Full-Text PDF

Essential Trace Element Status in Systemic Lupus Erythematosus: a Meta-analysis Based on Case-Control Studies.

Biol Trace Elem Res 2022 Jun 24. Epub 2022 Jun 24.

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.

The homeostasis of trace elements is essential to regulate different aspects of the immune system and might play important roles in systemic lupus erythematosus (SLE). However, epidemiological evidences that compared the level of essential trace elements in SLE patients and healthy controls (HCs) did not reach a consensus. This was the first meta-analysis to comprehensively assess the level of zinc (Zn), copper (Cu), iron (Fe), and selenium (Se) in SLE and HCs. Read More

View Article and Full-Text PDF

Predictive model of risk and severity of enteritis in systemic lupus erythematosus.

Lupus 2022 Jun 24:9612033221110743. Epub 2022 Jun 24.

Department of Rheumatology and Immunology, 499791Shantou Central Hospital, Shantou, China.

Introduction: To describe the clinical and laboratory features of systemic lupus erythematosus (SLE) enteritis and to establish a predictive model of risk and severity of lupus enteritis (LE).

Methods: Records of patients with SLE complaining about acute digestive symptoms were reviewed. The predictive nomogram for the diagnosis of LE was constructed by using R. Read More

View Article and Full-Text PDF

Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.

J Ethnopharmacol 2022 Jun 21;296:115496. Epub 2022 Jun 21.

Hospital of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China. Electronic address:

Ethnopharmacological Relevance: Tripterygium wilfordii polyglycosides (TWP) are extracted from Tripterygium wilfordii Hook. f., which has the significant effects of anti-inflammation and immunosuppression and has been widely used to treat autoimmune diseases in traditional Chinese medicine. Read More

View Article and Full-Text PDF

A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.

Clin Rev Allergy Immunol 2022 Jun 24. Epub 2022 Jun 24.

GENYO. Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Av de la Ilustración 114, Parque Tecnológico de La Salud, 18016, Granada, Spain.

Systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren's syndrome are four major autoimmune rheumatic diseases characterized by the presence of autoantibodies, caused by a dysregulation of the immune system that leads to a wide variety of clinical manifestations. These conditions present complex etiologies strongly influenced by multiple environmental and genetic factors. The human leukocyte antigen (HLA) region was the first locus identified to be associated and still represents the strongest susceptibility factor for each of these conditions, particularly the HLA class II genes, including DQA1, DQB1, and DRB1, but class I genes have also been associated. Read More

View Article and Full-Text PDF

EMBRACE: One Small Story in Lupus-One Giant Challenge in Clinical Trials.

ACR Open Rheumatol 2022 Jun 24. Epub 2022 Jun 24.

GlaxoSmithKline, Collegeville, Pennsylvania, USA.

Clinical trials of novel therapeutics in the United States have not been adequately representative of diverse populations, particularly racial and ethnic minorities. The challenges and consequences of underrepresentation in clinical trial recruitment are exemplified by the case of belimumab, a biologic treatment for systemic lupus erythematosus (SLE), a disease that is more prevalent in patients of Black African ancestry and of Hispanic/Latino ethnicity than in other patient populations. Although belimumab was found to be effective in phase 2 and 3 clinical trials in the general population, post hoc analyses of efficacy data in patients of Black African ancestry showed inconsistent results. Read More

View Article and Full-Text PDF

Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Front Oncol 2022 7;12:854499. Epub 2022 Jun 7.

Department of Rheumatology & Immunology, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.

A complex relationship exists between rheumatic diseases and cancer. This delicate balance between chronic inflammation and malignant cell transformation in hematologic neoplasms has been observed, but is not well defined. Large Granular Lymphocyte (LGL) leukemia is at the intersection of a clonal lymphoproliferative disease, chronic inflammation, and autoimmunity. Read More

View Article and Full-Text PDF

LNCRNA XIST Inhibits miR-377-3p to Hinder Th17 Cell Differentiation through Upregulating ETS1.

Comput Intell Neurosci 2022 14;2022:6545834. Epub 2022 Jun 14.

Beijing IROT Key Laboratory, The 8th Medical Center of Chinese PLA General Hospital, 100091 Beijing City, China.

Background: Th17 cell differentiation is involved in the development and progression of many diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Present study mainly focused on the role of LINC-XIST in Th17 cell differentiation.

Methods: The naïve CD4+ T cells were isolated from human whole blood. Read More

View Article and Full-Text PDF

Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study.

Vaccines (Basel) 2022 May 26;10(6). Epub 2022 May 26.

Division of Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

Background: Impaired immune responses to COVID-19 vaccines have been observed in autoimmune rheumatic disease patients. Determining the most effective and safe vaccine regimen is critically needed in such a population. We aim to compare the immunogenicity and safety of three COVID-19 vaccine regimens in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Read More

View Article and Full-Text PDF

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome.

J Clin Med 2022 Jun 20;11(12). Epub 2022 Jun 20.

Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.

Anti-Ki/SL antibodies were first described in 1981 and have been associated with systemic lupus erythematosus (SLE) and Sicca syndrome. Despite the long history, very little is known about this autoantibody system, and significant confusion persists. Anti-Ki/SL antibodies target a 32 kDa protein (also known as PSME3, HEL-S-283, PA28ƴ, REGƴ, proteasome activator subunit 3), which is part of the proteasome complex. Read More

View Article and Full-Text PDF

Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach.

J Clin Med 2022 Jun 15;11(12). Epub 2022 Jun 15.

Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.

Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease, and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to standard treatment. Therefore, new agents are required to allow for a more personalized therapeutic approach. Recently, several new therapies have been approved internationally, including voclosporine for LN and anifrolumab for moderately to severely active SLE. Read More

View Article and Full-Text PDF

The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients.

J Clin Med 2022 Jun 12;11(12). Epub 2022 Jun 12.

Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza University of Rome, Viale del Policlnico 155, 00161 Rome, Italy.

Objective: The purpose of this study was to determine the distribution of organ damage in a cohort of systemic lupus erythematosus (SLE) patients and to evaluate the roles of clinical and genetic factors in determining the development of chronic damage.

Methods: Organ damage was assessed by the SLICC Damage Index (SDI). We analyzed a panel of 17 single-nucleotide polymorphism (SNPs) of genes already associated with SLE, and we performed a phenotype-genotype correlation analysis by evaluating specific domains of the SDI. Read More

View Article and Full-Text PDF